• The study demonstrated the efficacy of Gelclair^® in patients undergoing different chemotherapy treatments. 

• More than the 80% of patients reported a benefit in pain management and in functionality.
•  In 57% of patients the grade of mucositis decreased after 3 days of Gelclair^® application.

Reference:
De Cordi D et al, Presented at the Italian Anti Tumor League III Congress of Professional Oncology Nurses Conegliano, October 10-12, 2001.